Let's focus on what we can do!

By Disabled People for Disabled People

  • Home
  • >
  • Latest Headlines
  • >
  • Target Enrollment in Child Spinal Muscular Atrophy Study Earns Ionis $2M Payment From Biogen – SMA News Today

Target Enrollment in Child Spinal Muscular Atrophy Study Earns Ionis $2M Payment From Biogen – SMA News Today

Sunday, 31 January, 2016

Target Enrollment in Child Spinal Muscular Atrophy Study Earns Ionis $2M Payment From Biogen – SMA News Today

Ionis Pharmaceuticals announced it has completed its target enrollment of the Phase 3 CHERISH study, a trial designed to support marketing approval of the drug candidate nusinersen in children with spinal muscular atrophy (SMA). The achievement earned ...

Read More

Source:Target Enrollment in Child Spinal Muscular Atrophy Study Earns Ionis $2M Payment From Biogen - SMA News Today

Categories :
  • Latest Headlines
  • Spinal muscular atrophy
  • Uncategorized
Socials :

Recent posts